$0.31 Earnings Per Share Expected for MedEquities Realty Trust Inc (MRT) This Quarter

Analysts expect MedEquities Realty Trust Inc (NYSE:MRT) to post earnings of $0.31 per share for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for MedEquities Realty Trust’s earnings. The lowest EPS estimate is $0.30 and the highest is $0.32. MedEquities Realty Trust reported earnings of $0.27 per share during the same quarter last year, which indicates a positive year-over-year growth rate of 14.8%. The business is scheduled to announce its next quarterly earnings results before the market opens on Wednesday, February 21st.

According to Zacks, analysts expect that MedEquities Realty Trust will report full-year earnings of $1.12 per share for the current financial year, with EPS estimates ranging from $1.11 to $1.13. For the next financial year, analysts expect that the firm will post earnings of $1.26 per share, with EPS estimates ranging from $1.18 to $1.34. Zacks Investment Research’s EPS calculations are an average based on a survey of research analysts that cover MedEquities Realty Trust.

MedEquities Realty Trust (NYSE:MRT) last posted its earnings results on Tuesday, November 7th. The financial services provider reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.13). MedEquities Realty Trust had a net margin of 35.61% and a return on equity of 5.88%. The firm had revenue of $15.77 million during the quarter, compared to the consensus estimate of $15.49 million.

A number of analysts have commented on the stock. B. Riley reaffirmed a “buy” rating on shares of MedEquities Realty Trust in a report on Wednesday, November 1st. Capital One Financial reissued an “equal weight” rating on shares of MedEquities Realty Trust in a report on Sunday, October 22nd. KeyCorp set a $13.00 price target on shares of MedEquities Realty Trust and gave the company a “buy” rating in a report on Sunday, October 29th. Zacks Investment Research raised shares of MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 price target for the company in a report on Wednesday, November 15th. Finally, ValuEngine raised shares of MedEquities Realty Trust from a “hold” rating to a “buy” rating in a report on Friday, December 1st. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $13.00.

MedEquities Realty Trust (NYSE MRT) traded down $0.23 on Monday, reaching $10.87. 153,739 shares of the company’s stock were exchanged, compared to its average volume of 159,618. MedEquities Realty Trust has a 12-month low of $10.06 and a 12-month high of $13.06. The firm has a market cap of $352.49, a price-to-earnings ratio of 27.18 and a beta of -0.74.

In related news, Director Randy L. Churchey bought 5,300 shares of MedEquities Realty Trust stock in a transaction that occurred on Monday, November 20th. The stock was purchased at an average cost of $10.87 per share, with a total value of $57,611.00. Following the purchase, the director now owns 46,776 shares in the company, valued at $508,455.12. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO John W. Mcroberts bought 18,000 shares of MedEquities Realty Trust stock in a transaction that occurred on Friday, November 17th. The stock was bought at an average cost of $10.74 per share, with a total value of $193,320.00. The disclosure for this purchase can be found here. Insiders bought a total of 23,600 shares of company stock valued at $254,129 in the last three months. 2.50% of the stock is owned by company insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. bought a new stake in MedEquities Realty Trust during the 3rd quarter worth about $118,000. Raymond James Financial Services Advisors Inc. bought a new stake in shares of MedEquities Realty Trust in the 2nd quarter valued at about $154,000. Alliancebernstein L.P. bought a new stake in shares of MedEquities Realty Trust in the 2nd quarter valued at about $175,000. Cubist Systematic Strategies LLC bought a new stake in shares of MedEquities Realty Trust in the 3rd quarter valued at about $177,000. Finally, Dynamic Technology Lab Private Ltd raised its holdings in shares of MedEquities Realty Trust by 25.1% in the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 16,686 shares of the financial services provider’s stock valued at $210,000 after purchasing an additional 3,346 shares during the period. 93.21% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “$0.31 Earnings Per Share Expected for MedEquities Realty Trust Inc (MRT) This Quarter” was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/29/0-31-earnings-per-share-expected-for-medequities-realty-trust-inc-mrt-this-quarter.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply